Valeant's response to controversy is 'nonsense,' says short seller | Fortune
Fahmi Quadir: the short-selling dynamo
Exclusive: SEC probe of Valeant began with review of short seller - sources | Reuters
Valeant's Epic 90% Plunge: A Timeline of How it Happened | Fortune
Famed short-seller Chanos can't cash in on Valeant
Valeant 'short' smells smoke — even when there's no fire
What Valeant's fall from grace can teach the drug industry
Hacked Printers. Fake Emails. Questionable Friends. Fahmi Quadir Was Up 24% Last Year, But It Came at a Price. | Institutional Investor
Dirty Money" Drug Short (TV Episode 2018) - IMDb
Valeant scandal shows why we need short-sellers in the stock market - Los Angeles Times
Fahmi Quadir: A Short Seller named Assassin | LGT
Jim Chanos: I'm still short Valeant and not about to quit
Valeant Plunges 30% After Short Seller Citron Research Makes Fraud Allegation
Valeant: Yes, Ackman's a Loser. But How Much Did Short Sellers Make? | Barron's
5 Most Successful Short Sellers of All Time - Insider Monkey
Hacked Printers. Fake Emails. Questionable Friends. Fahmi Quadir Was Up 24% Last Year, But It Came at a Price. | Institutional Investor
Valeant scandal shows why we need short-sellers in the stock market - Los Angeles Times
Valeant shares recoup losses after company rejects short seller report - MarketWatch
The Valeant Meltdown and Wall Street's Major Drug Problem | Vanity Fair
Netflix's 'Dirty Money' Exposes the Corporate Corruption Running the World | GQ
The Anti-Ackman: Valeant Short Sellers Have Made $2.8 Billion - Bloomberg
Short Seller Says Valeant Uninvestable
Here's how much Valeant short sellers have been killing it ever since Bill Ackman got in the stock
Valeant shares plunge on short-seller scrutiny of pharmacy revenue | Reuters
The 'Short' Who Sank Valeant Stock - WSJ
Valeant Short Seller Dials Back Warning of Bombshell Report on Monday - WSJ
